21-Fold Higher COVID-19 Mortality Rate in Patients with Severe Renal Dysfunction on Admission
Urology Journal,
Vol. 20 No. 04 (2023),
2 October 2023
,
Page 276-277
https://doi.org/10.22037/uj.v18i.6891
Abstract
Keywords:
- estimated glomerular filtration rate COVID-19, Outcome, Mortality, length of stay in hospital
How to Cite
Ghorbani, H., Golshan, A., Aghaee, A., Mottaghi , M. ., & Soltani, S. (2023). 21-Fold Higher COVID-19 Mortality Rate in Patients with Severe Renal Dysfunction on Admission. Urology Journal, 20(04), 276–277. https://doi.org/10.22037/uj.v18i.6891
References
References
1. Deng S-Q, Peng H-JJJocm. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. 2020;9(2):575.
2. Sobhani S, Aryan R, Kalantari E, Soltani S, Malek N, Pirzadeh P, et al. Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients: A Report from Northeast Iran. 2021;2021.
3. Sobhani S, Kazemi A, Kalantari F, Soltani S, Vakili S, Yarahmadi A, et al. Hematological and Biochemical Parameters Associated with Mortality in COVID-19 Infection and Their Correlation with Smoking. 2021;9(1):41-6.
4. Wang T, Hu M, Chen X, Fu Y, Lei C, Dong H, et al. Caution on kidney dysfunctions of 2019-nCoV patients. 2020.
5. Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HH, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. 2020;8(8):e1003-e17.
6. Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, et al. Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. 2021;77(2):190-203. e1.
7. Hachim IY, Hachim MY, Naeem KB, Hannawi H, Al Salmi I, Al-Zakwani I, et al. Kidney dysfunction among COVID-19 patients in the United Arab Emirates. 2021;36(1):e221.
8. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro III AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. 2009;150(9):604-12.
9. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. 2020;369.
10. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. 2020;97(5):829-38.
11. Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. 2020;55(5).
12. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. 2020;382(18):1708-20.
13. Wu Z, McGoogan JMJJ. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. 2020;323(13):1239-42.
14. Ishigami J, Matsushita KJC, nephrology e. Clinical epidemiology of infectious disease among patients with chronic kidney disease. 2019;23(4):437-47.
1. Deng S-Q, Peng H-JJJocm. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. 2020;9(2):575.
2. Sobhani S, Aryan R, Kalantari E, Soltani S, Malek N, Pirzadeh P, et al. Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients: A Report from Northeast Iran. 2021;2021.
3. Sobhani S, Kazemi A, Kalantari F, Soltani S, Vakili S, Yarahmadi A, et al. Hematological and Biochemical Parameters Associated with Mortality in COVID-19 Infection and Their Correlation with Smoking. 2021;9(1):41-6.
4. Wang T, Hu M, Chen X, Fu Y, Lei C, Dong H, et al. Caution on kidney dysfunctions of 2019-nCoV patients. 2020.
5. Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HH, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. 2020;8(8):e1003-e17.
6. Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, et al. Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. 2021;77(2):190-203. e1.
7. Hachim IY, Hachim MY, Naeem KB, Hannawi H, Al Salmi I, Al-Zakwani I, et al. Kidney dysfunction among COVID-19 patients in the United Arab Emirates. 2021;36(1):e221.
8. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro III AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. 2009;150(9):604-12.
9. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. 2020;369.
10. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. 2020;97(5):829-38.
11. Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. 2020;55(5).
12. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. 2020;382(18):1708-20.
13. Wu Z, McGoogan JMJJ. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. 2020;323(13):1239-42.
14. Ishigami J, Matsushita KJC, nephrology e. Clinical epidemiology of infectious disease among patients with chronic kidney disease. 2019;23(4):437-47.
- Abstract Viewed: 138 times
- 6891/pdf Downloaded: 117 times